This topic contains a solution. Click here to go to the answer

Author Question: Which of the following types of land interests is not subject to the Rule Against Perpetuities? A) ... (Read 33 times)

nummyann

  • Hero Member
  • *****
  • Posts: 576
Which of the following types of land interests is not subject to the Rule Against Perpetuities?
 A) Executory interest
 B) Contingent remainder
 C) Vested remainder subject to complete divestment
 D) None of the above

Question 2

A seller may cancel a sales contract if the buyer does any of the following except:
 A) wrongfully rejects the goods.
 B)repudiates the contract.
 C) fails to make a payment due on or before delivery.
 D) rejects an improper tender.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Meganchabluk

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

C

Answer to Question 2

D




nummyann

  • Member
  • Posts: 576
Reply 2 on: Jun 24, 2018
Excellent


steff9894

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library